T1	Participants 403 439	chronic heart failure (CHF) patients
T2	Participants 565 730	37 CHF patients (New York Heart Association Functional Class=2.3±0.5; left ventricular ejection fraction 28±7%; age 64±12years; 32:5 male:female) who were randomised
